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Abstract
HIV testing and counseling (HTC) is an essential component of comprehensive HIV programs. 
Retrospective HTC program data from 2006 to 2010 were examined to determine patterns of re-
testing and seroconversion in Lesotho. Among 104,662 initially negative clients, 6,777 (6.5%) 
were re-testers. Predictors of re-testing included being male, age ≥ 25 years, divorced/separated, 
having more than a high school education, being tested as a couple, testing in the year 2006, 
testing in the capital city, and awareness of partner’s recent testing behavior. Among re-testers 
who seroconverted (N = 259), predictors included being female and having less than a high school 
education. There is a critical need for more effectively targeting HIV retesting messages to align 
with WHO (2010) guidelines and identify persons at highest risk for HIV, to increase timely 
diagnoses and link persons to appropriate HIV prevention, care, and treatment services.
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HIV testing and counseling (HTC) is essential to identify HIV-infected persons in need of 
care and treatment, and to provide targeted HIV prevention services. Worldwide, uptake of 
HTC has been steadily increasing, due to the increase in provider-initiated testing in health 
care facilities and continued growth in testing sought at fixed voluntary counseling and 
testing (VCT) sites and via mobile HTC services (World Health Organization, United 
Nations Program on HIV & AIDS, & UNICEF [UNAIDS], 2013). In some countries, repeat 
HIV testing, or re-testing (i.e., returning for a test after an initial HIV-negative test), has 
accounted for one-third to two-thirds of self-initiated HIV tests (Fernyak, Page-Shafer, 
Kellogg, McFarland, & Katz, 2002; Leaity, 2000; MacKellar et al., 2002; Matovu et al., 
2007). Reports vary considerably on frequency of re-testing, characteristics of re-testers, and 
rates of HIV diagnoses among re-testing clients. In rural Tanzania, only 25% of those 
surveyed reported ever repeat tested (Cawley et al., 2013), and a similar rate (26%) was 
observed in outpatient HTC settings in South Africa (Regan et al., 2013). Among VCT 
clients re-tested in Namibia, most did so 6 months after their initial test despite being told to 
come back in 3 months, and approximately 1.5% of re-testers seroconverted between their 
first and last HIV test (Wolmarans & Koppenhaver, 2008).
In 2010, the World Health Organization (WHO; 2010) issued recommendations to 
encourage more targeted re-testing, and to identify situations where retesting is not 
necessary (WHO, 2010). These guidelines suggest at least annual retesting for populations at 
high risk of seroconversion; e.g., HIV-negative partners in serodiscordant relationships, men 
who have sex with men, persons who engage in sex work, and the general population in 
countries with high prevalence. Four-week repeat testing is recommended for persons with a 
known recent exposure or who are at risk of acute infection, which revises earlier 
recommendations for repeat testing at 3-months to rule out error due to the test’s window 
period (i.e., the time interval between HIV infection and the development of detectable HIV 
antibodies). These recommendations were revised as, in more recent years, HIV tests have 
become available that can detect HIV antigen and/or antibodies much sooner than three 
months following infection.
Despite WHO’s recommendations, HTC guidelines in many countries continue to 
recommend that persons at risk of infection should be re-tested three months after a negative 
test result (Government of Lesotho, 2009). In Lesotho, counselors at VCT sites are trained to 
recommend re-testing to persons with a recent exposure (i.e., within the last three months), 
but VCT counselors often give this recommendation to all clients, regardless of their risk or 
timing of their last potential exposure (Population Services International Lesotho, personal 
communication). The generic recommendation becomes diluted, clients may or may not 
return for re-testing, and often when they do return, more than three months has passed since 
their initial test. It is important that HTC counselors follow WHO recommendations 
regarding retesting within the appropriate recommended time frames in order to more 
accurately identify persons at highest risk of having acute HIV infection, and to minimize 
unnecessary re-testing (WHO, 2010).
The Kingdom of Lesotho is a small, landlocked country located within the borders of South 
Africa, with a population of 1.9 million people and an estimated 23% of adults aged 15–49 
living with HIV (UNAIDS, 2013). The proportion of Basotho (persons from Lesotho) who 
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have ever been tested for HIV and received their HIV test results increased between 2004 
and 2009, from 15% to 69% among women and from 11% to 39% among men (Cawley et 
al., 2013; UNAIDS, 2013). However, rates and patterns associated with re-testing have not 
been examined among Basotho. To understand whether clients seeking re-testing services 
report higher risk behaviors, whether persons who seroconvert exhibit characteristics that 
can inform how programs target services, and whether the timeframe of re-testing is 
consistent with international guidance, we analyzed routinely-collected data from HTC sites 
in Lesotho.
METHODS
ETHICAL REVIEW
This protocol was reviewed and approved by U.S. Centers for Disease Control and 
Prevention (CDC) in Atlanta, and the Lesotho Ministry of Health and Social Welfare 
(MOHSW). This evaluation was determined to be research not involving human subjects, 
since only retrospective client intake records were analyzed. No personal identifiers were 
used, client identification numbers cannot be traced back to individual persons.
DESIGN
We conducted a retrospective analysis of client intake records collected as part of routine 
program monitoring in Lesotho HTC sites between January 2006 and June 2010. These 
records included all testing conducted at each site, including mobile and outreach services. 
Data from the intake records were entered into a central database at each site daily, and data 
cleaning and reporting was conducted monthly. Each client intake record was coded with a 
unique client identification (CID) number. Clients were provided with a copy of their CID 
and asked to bring the card back upon return visits. These forms did not link to client names 
or other identifying information. Therefore, if clients did not bring back their CID upon 
subsequent visits, they were issued a new CID.
SETTINGS
During the data collection period, Population Services International (PSI) managed five 
stand-alone VCT sites in Lesotho, located in Maseru (the capital city), Mafeteng, Maputsoe 
(Leribe), Butha Buthe, and Qachas Nek; these sites also offered mobile and outreach 
services. This program represented a large proportion of HTC provided at the time in 
Lesotho.
Participants—Records were reviewed for all clients aged 15 years and older for whom an 
intake form was completed, including assignment of a CID, and test results recorded at any 
of the HTC sites during the 4.5-year data collection period. A confirmed re-tester was 
defined as anyone who received an initial HIV test and at least one subsequent HIV test 
documented during the data collection period. Confirmation of the re-test was performed by 
matching CIDs recorded on the intake forms. Seroconverters were defined as individuals 
who initially tested HIV-negative and who subsequently tested HIV-positive within the data 
collection period. Figure 1 illustrates the flow of clients, including the total tested (N = 
128,522), those who were HIV-negative at the initial test and did not have a subsequent test 
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recorded (n = 97,885), and the serostatus of persons who had more than one recorded test 
result (n = 6,777).
Measures—As part of routine program activities, HTC providers completed an intake 
form for all clients attending an HTC session. In addition to recording the date, site, and type 
of visit, the form collected basic sociodemographic information, HIV testing history of the 
client and client’s partner, several items assessing behavioral risk for HIV, as well as HIV 
test results. Sociodemographic information, testing history and risk behavior were based on 
client self-report.
Forms were revised in October 2008, affecting the way several measures were collected. 
Where measures varied across the two versions of the intake form, categories were collapsed 
into comparable groupings.
STATISTICAL ANALYSIS
Univariate analyses were conducted to determine HIV prevalence among all clients tested. 
For clients with an initial negative test result, we used Pearson’s chi-square to compare re-
testers and non-re-testers on demographic and behavioral characteristics. For re-testers who 
had an initial negative test result, we compared seroconverters to nonseroconverters in a 
similar fashion. Odds ratios (OR) and two-sided 95% confidence intervals (CIs) were 
calculated by logistic regression. All of the client characteristics with P value < .20 were 
included in multivariable models, and age was included because of its association with HIV 
prevalence. In the multivariable model to compare seroconverters to nonseroconverters, we 
assessed interaction between gender and other characteristics.
We plotted re-testing and seroconversion by time from initial HIV-negative test in order to 
assess patterns among these groups. The probability of remaining un-infected among re-
testers was calculated using the nonparametric maximum likelihood estimator to account for 
interval-censored data for the seroconversions. All analyses were performed using SAS 
software version 9.3 (SAS Institute Inc, 2011). Statistical significance was assessed at the 
0.05 level for all analyses.
RESULTS AND DISCUSSION
CLIENT CHARACTERISTICS
Client intake records were available for 157,947 nonduplicated records. Of these, 
approximately 11.5% were excluded for missing key elements (e.g., CID, testing date). Of 
the records that remained, 128,522 unique clients were identified for analyses. At their 
initial recorded visit, 27% self-reported previous testing for HIV. This could be over-
reporting, or could include persons who could not be confirmed re-testers because of 
missing CID. The largest proportions of clients were tested in Maseru, the capital city (Table 
1). More women than men tested for HIV, and a large proportion of persons who tested were 
over the age of 25. Higher prevalence of HIV was observed among first-time clients in 
Maseru and Leribe compared to clients from other sites. At initial test, a total of 18.6% (n = 
23,860) of HTC clients were HIV-positive.
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In terms of HIV-related risk behavior, 17% of clients reported that their partner had been 
recently tested for HIV, i.e., in the past 3 months. While very small percentages of clients 
reported having sex while intoxicated or exchanging money or other goods for sex, HIV 
prevalence among clients who reported these behaviors was twice as high as it was among 
clients not reporting these behaviors. Having any unprotected sex was associated with more 
than three times as high a prevalence of HIV (Table 1).
RE-TESTING
Of the 6.5% (n = 6,777) of HTC clients who were confirmed re-testers, 15.1% (n = 1,025) 
re-tested within 0–91 days, with a substantial proportion re-testing in weeks 1–2 (Figure 2). 
Most clients who re-tested did so within one year of the initial HIV-negative result (85.3%). 
The largest proportion re-tested within 4–6 months (47.4%), with a peak at 13 weeks, 
suggesting that many were heeding recommendations to return in 3 months. Of the 6,777 re-
testers, most re-tested only once during the data collection period (76.6%, n = 5,191; 
Courtenay-Quirk, Grabbe, Baughman, Djomand, & Pederson 2013). A lesser number 
(16.1%, n = 1,090) re-tested twice following the initial HIV-negative result, with a median 
of 192 days between the last two tests (interquartile range = 126–308).
Compared to HIV-negative persons who did not re-test, re-testers were more likely to have 
been tested at Maseru, tested in 2006, to be male, age ≥ 25, divorced or separated, and had 
more than a high school education (Table 1). HTC clients were also more likely to re-test if 
they had tested as a couple, were aware of whether their partner had recently, i.e., in the past 
3 months, tested for HIV (compared to those who did not know if their partner had been 
tested), and reported unprotected sex.
SEROCONVERSION
Of the HIV-negative persons who returned for at least one re-test, 3.8% (259) tested HIV-
positive at a subsequent test (Figure 2). Among all seroconverters, the temporal sequence 
indicates that a total of 54 persons (21%) tested HIV-positive within 12 weeks of the last 
HIV-negative test. Of these, 44 tested HIV-positive by week 4 (17% of all seroconverters 
and 81% of seroconverters within 12 weeks). A total of 130 (50%) persons tested HIV-
positive between week 13 and week 52. Among seroconverters, the median time between 
the first HIV-negative and a subsequent HIV-positive result was 106 days (interquartile 
range, 48 to 226 days). In the cohort of all re-testers, 95.6% remained negative at 1 year, 
93.4% at 2 years, and 87.5% at 3 years.
Women were twice as likely as men to seroconvert upon subsequent HIV testing (Table 2). 
Compared to persons who reported more than a high school education, persons with less 
education were more likely to seroconvert. Clients who knew that their partner had not 
recently tested for HIV were more likely than others to seroconvert in the bivariate analyses, 
but this association was not significant in the multivariable analysis.
The HTC program in Lesotho may have attracted a slightly different set of repeat testers 
than other settings, as other studies have reported higher rates of repeat testing among 
women (Regan et al., 2013). Many other factors, such as attitudes and knowledge about 
Grabbe et al. Page 5
AIDS Educ Prev. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
HIV, the increase in mobile testing, availability of new rapid testing technology, background 
HIV prevalence and national prevention efforts may have influenced the patterns and 
motivations of re-testing in Lesotho. The models of testing also shifted over time to increase 
availability of mobile testing. Previous studies conducted among repeat testers have found 
mixed results as to the association between risk behavior and repeat testing (Bradley, Tsui, 
Kidanu, & Gillespie, 2011; Houdmont, Munir, & Grey, 2013; Leaity et al., 2000; 
Nascimento, 2004; Norton, Elford, Sherr, Miller, & Johnson, 1997; Ryder et al., 2005).
Over time, 3.8% of clients with a recorded re-test had seroconverted. Given the expected lag 
between an infection event and the point at which a person’s immune system has developed 
a detectable antibody response, it is likely that many of the 17% of seroconverters who 
tested HIV-positive within 4 weeks of their initial HIV-negative test were infected with HIV
—or were in the acute HIV infection period—when previously tested (Patel, 2010; Pilcher, 
2013). These are high risk clients who should receive targeted messages about acute 
infection, re-testing, and how to prevent transmission until diagnosis is confirmed or 
dismissed. The very few (4%) who seroconverted between weeks 4 and 12 supports the 
2010 WHO guidelines to recommend re-testing within 4 weeks for a known exposure. The 
peak in re-testing between 12–18 weeks following the initial test, however, suggests that 
many clients may have been following a 3-month recommendation.
Predictors for HIV seroconversion included being female and having less than a high school 
education. Several explanations may account for these associations, including biological 
factors that put women at increased risk, socio-cultural reasons such as age-discordant 
mixing (Kelly et al., 2003; Ott, Barnighausen, Tanser, Lurie, & Newell, 2011) and gender 
norms that give women less power than men in marriage and sexual relationships (Harrison, 
Short, & Tuoane-Nkhasi, 2013). Lower educational attainment was independently 
associated with HIV risk, reflecting a trend observed throughout Africa (Hargreaves, 2008). 
Persons who are less educated may have lower awareness of HIV risk, and may have lower 
socio-economic status, leading them to participate in higher-risk behaviors such as 
transactional sex.
While the association with seroconversion of knowing the partner had not recently tested for 
HIV was not maintained in the multivariable analysis, it highlights the important counseling 
component of programs to encourage sexual partners to test and to be aware of one another’s 
HIV status. Couples HTC is one strategy for increasing partner testing and mutual 
disclosure, which should also be encouraged in order to dispel myths about serodiscordance 
and establish prevention plans based on both partners’ HIV status.
Our study has a number of limitations. Because we used retrospective and incomplete 
programmatic data, not all records could be used. Therefore these results may not represent 
all re-testers in Lesotho. Some variables, such as occupation, were also not evaluated 
because they were unable to be analyzed. Because our study involved VCT and mobile HTC 
clients, the results may not reflect patterns of HIV testing that occur elsewhere, e.g., public 
clinics, hospitals, or the private sector. The available data also did not allow us to compare 
between clients of mobile testing and VCT sites. Additionally, if clients did not return with 
their client ID card, the programs were not able to track previous tests for that individual. It 
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is also possible that clients could have re-tested at a clinic not included in this study. Our 
counts of re-testers are therefore likely to be underestimates and are lower than those 
reported in other studies.
CONCLUSIONS
We examined patterns of re-testing and seroconversion in a large cohort of HTC clients 
from stand-alone and mobile HTC sites in Lesotho over a 4.5-year period. HIV testing offers 
a critical opportunity to diagnose HIV infection and link to HIV medical care and treatment 
services, and to identify high-risk HIV-negative clients who would benefit from targeted 
HIV prevention services, including re-testing. Among those who seroconverted in this study, 
17% were probably already infected when last tested: these are persons for whom it is very 
important to target messages about acute infection, re-testing, and linkage to care. A 
substantial majority of persons who re-tested remained HIV-negative on their subsequent 
visits, and may not have needed re-testing sooner than the 1 year recommended by WHO.
There is a critical need for more targeted prevention services in Lesotho, particularly for 
women and persons with lower levels of education, and a need for increased emphasis on 
the importance of partner HIV testing and disclosure in preventing HIV transmission. 
Consistent with WHO recommendations, HTC programs should update policies to ensure 
that all counselors and health workers giving HIV test results are trained to encourage re-
testing within 4 weeks if the client reports recent risk, and at least annually within 
populations at higher risk (UNAIDS, 2013). Tools and training should be developed to help 
counselors identify and provide tailored messages to higher-risk clients, and testing 
programs should track re-testers and those who seroconvert to ensure early enrollment in 
care.
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FIGURE 1. 
Flowchart of clients attending voluntary HIV testing and counseling (HTC) facilities in 
Lesotho, January 2006–June 2010.
Grabbe et al. Page 10
AIDS Educ Prev. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
FIGURE 2. 
Percentage of clients re-tested by weeks from initial HIV-negative test to re-test (n = 6,777) 
and percentage re-tested who seroconverted by weeks from initial HIV-negative test to HIV-
positive re-test (n = 259).
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nt
s.
c I
n 
th
e 
pr
e-
20
08
 fo
rm
, t
he
se
 q
ue
sti
on
s w
er
e 
as
ke
d 
on
ly
 fo
r t
he
 p
as
t 1
2 
m
on
th
s, 
w
he
re
as
 in
 th
e 
po
st-
20
08
 fo
rm
, t
he
se
 q
ue
sti
on
s w
er
e 
as
ke
d 
as
 e
ve
r.
d I
n 
th
e 
po
st-
20
08
 fo
rm
, t
w
o 
se
pa
ra
te
 q
ue
sti
on
s w
er
e 
as
ke
d,
 o
ne
 fo
r s
ex
 w
ith
 a
 re
gu
la
r p
ar
tn
er
 a
nd
 a
no
th
er
 fo
r s
ex
 w
ith
 a
 n
on
re
gu
la
r p
ar
tn
er
; a
 c
om
po
sit
e 
va
ria
bl
e 
w
as
 c
re
at
ed
 a
nd
 c
od
ed
 Y
es
 if
 e
ith
er
 
qu
es
tio
n’
s r
es
po
ns
e 
w
as
 a
ns
w
er
ed
 Y
es
, o
th
er
w
ise
 N
o.
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